drugset / Trial / NCT05475847
Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer
NaSingle-groupOpen-labelTreatment
Summary
A study that aimed to assess the safety and anti-tumor activity of C-TIL052A cell therapy in subjects with persistent, recurrent and/or metastatic cervical cancer.
Timeline
- Start
- 2022-07
- Primary completion
- 2025-07
- Completion
- 2025-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C-TIL052A | Cell therapy | — | Other |
| Background | aldesleukin | Protein / enzyme biologic | — | Other |